Journal of Controlled Release, volume 321, pages 442-462

Recent advances in nanotechnology-based drug delivery systems for the kidney.

Oroojalian Fatemeh ¹

Charbgoo Fahimeh ²

Hahsemi Maryam ³

Amani Amir ^{4, 5}

Yazdian-Robati Rezvan ⁶

Mokhtarzadeh Ahad ⁷

Ramezani Mohammad H. ^{8, 9}

Hamblin Michael ^{10, 11}

Hide authors affiliations Show authors affiliations: 11 affiliations

Department of Advanced Sciences and Technologies, North Khorasan University of Medical Sciences, Bojnurd, Iran. |

DWI - Leibniz Institute for Interactive Materials , Forckenbeckstr. 50, 52056 Aachen, Germany. |

Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran |

⁴

Department of Advanced Sciences and Technologies, North Khorasan University of Medical Sciences, Bojnurd, Iran |

⁵

Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. |

⁶

Molecular and Cell biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran |

⁷

Immunology Research Center , Tabriz University of Medical Sciences , Tabriz , Iran |

⁸

Department of Pharmaceutical Biotechnology, School of Pharmacy

⁹

Mashhad University of Medical Sciences, Mashhad, Iran |

¹⁰

Laser Research Centre Faculty of Health Science University of Johannesburg Doornfontein 2028 South Africa |

¹¹

Wellman Center for Photomedicine Massachusetts General Hospital Boston MA 02114 USA |

Publication type: Journal Article

Publication date: 2020-05-01

Elsevier

Journal: Journal of Controlled Release

Quartile SCImago

Quartile WOS

Impact factor: 10.8

ISSN: 01683659, 18734995

DOI: 10.1016/j.jconrel.2020.02.027

Copy DOI

Pharmaceutical Science

Abstract

The application of nanotechnology in medicine has the potential to make a great impact on human health, ranging from prevention to diagnosis and treatment of disease. The kidneys are the main organ of the human urinary system, responsible for filtering the blood, and concentrating metabolic waste into urine by means of the renal glomerulus. The glomerular filtration apparatus presents a barrier against therapeutic agents based on charge and/or molecular size. Therefore, drug delivery to the kidneys faces significant difficulties resulting in treatment failure in several renal disorders. Accordingly, different strategies have recently being explored for enhancing the delivery of therapeutic agents across the filtration barrier of the glomerulus. Nanosystems with different physicochemical properties, including size, shape, surface, charge, and possessing biological features such as high cellular internalization, low cytotoxicity, controllable pharmacokinetics and biodistribution, have shown promising results for renal therapy. Different types of nanoparticles (NPs) have been used to deliver drugs to the kidney. In this review, we discuss nanotechnology-based drug delivery approaches for acute kidney injury, chronic kidney disease, renal fibrosis, renovascular hypertension and kidney cancer.

By date By citations

Citations by journals

	2 4 6 8 10 12
Journal of Controlled Release	Journal of Controlled Release, 11, 11% Journal of Controlled Release 11 publications, 11%
Pharmaceutics	Pharmaceutics, 5, 5% Pharmaceutics 5 publications, 5%
Journal of Nanobiotechnology	Journal of Nanobiotechnology, 3, 3% Journal of Nanobiotechnology 3 publications, 3%
Nanoscale	Nanoscale, 3, 3% Nanoscale 3 publications, 3%
International Journal of Molecular Sciences	International Journal of Molecular Sciences, 2, 2% International Journal of Molecular Sciences 2 publications, 2%
Frontiers in Bioengineering and Biotechnology	Frontiers in Bioengineering and Biotechnology, 2, 2% Frontiers in Bioengineering and Biotechnology 2 publications, 2%
Molecules	Molecules, 2, 2% Molecules 2 publications, 2%
Biomaterials Research	Biomaterials Research, 2, 2% Biomaterials Research 2 publications, 2%
International Journal of Pharmaceutics	International Journal of Pharmaceutics, 2, 2% International Journal of Pharmaceutics 2 publications, 2%
Journal of Drug Delivery Science and Technology	Journal of Drug Delivery Science and Technology, 2, 2% Journal of Drug Delivery Science and Technology 2 publications, 2%
International Journal of Biological Macromolecules	International Journal of Biological Macromolecules, 2, 2% International Journal of Biological Macromolecules 2 publications, 2%
Small	Small, 2, 2% Small 2 publications, 2%
ACS applied materials & interfaces	ACS applied materials & interfaces, 2, 2% ACS applied materials & interfaces 2 publications, 2%
Langmuir	Langmuir, 2, 2% Langmuir 2 publications, 2%
Biotechnology Progress	Biotechnology Progress, 2, 2% Biotechnology Progress 2 publications, 2%
Nanomedicine	Nanomedicine, 2, 2% Nanomedicine 2 publications, 2%
Progress in Materials Science	Progress in Materials Science, 2, 2% Progress in Materials Science 2 publications, 2%
Biological and Pharmaceutical Bulletin	Biological and Pharmaceutical Bulletin, 1, 1% Biological and Pharmaceutical Bulletin 1 publication, 1%
Transplantation	Transplantation, 1, 1% Transplantation 1 publication, 1%
Hypertension	Hypertension, 1, 1% Hypertension 1 publication, 1%
Frontiers in Cell and Developmental Biology	Frontiers in Cell and Developmental Biology, 1, 1% Frontiers in Cell and Developmental Biology 1 publication, 1%
Cancers	Cancers, 1, 1% Cancers 1 publication, 1%
Pharmaceuticals	Pharmaceuticals, 1, 1% Pharmaceuticals 1 publication, 1%
AAPS PharmSciTech	AAPS PharmSciTech, 1, 1% AAPS PharmSciTech 1 publication, 1%
Applied Biochemistry and Biotechnology	Applied Biochemistry and Biotechnology, 1, 1% Applied Biochemistry and Biotechnology 1 publication, 1%
Nano Research	Nano Research, 1, 1% Nano Research 1 publication, 1%
European Journal of Pharmacology	European Journal of Pharmacology, 1, 1% European Journal of Pharmacology 1 publication, 1%
Food Hydrocolloids	Food Hydrocolloids, 1, 1% Food Hydrocolloids 1 publication, 1%
Fundamental Research	Fundamental Research, 1, 1% Fundamental Research 1 publication, 1%
	2 4 6 8 10 12

Citations by publishers

	5 10 15 20 25 30 35
Elsevier	Elsevier, 32, 32% Elsevier 32 publications, 32%
Multidisciplinary Digital Publishing Institute (MDPI)	Multidisciplinary Digital Publishing Institute (MDPI), 12, 12% Multidisciplinary Digital Publishing Institute (MDPI) 12 publications, 12%
Springer Nature	Springer Nature, 12, 12% Springer Nature 12 publications, 12%
Wiley	Wiley, 9, 9% Wiley 9 publications, 9%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 6, 6% Royal Society of Chemistry (RSC) 6 publications, 6%
American Chemical Society (ACS)	American Chemical Society (ACS), 5, 5% American Chemical Society (ACS) 5 publications, 5%
Frontiers Media S.A.	Frontiers Media S.A., 3, 3% Frontiers Media S.A. 3 publications, 3%
Wolters Kluwer Health	Wolters Kluwer Health, 2, 2% Wolters Kluwer Health 2 publications, 2%
Future Medicine	Future Medicine, 2, 2% Future Medicine 2 publications, 2%
Pharmaceutical Society of Japan	Pharmaceutical Society of Japan, 1, 1% Pharmaceutical Society of Japan 1 publication, 1%
KeAi Communications Co.	KeAi Communications Co., 1, 1% KeAi Communications Co. 1 publication, 1%
Dove Medical Press	Dove Medical Press, 1, 1% Dove Medical Press 1 publication, 1%
Walter de Gruyter	Walter de Gruyter, 1, 1% Walter de Gruyter 1 publication, 1%
Hindawi Limited	Hindawi Limited, 1, 1% Hindawi Limited 1 publication, 1%
Shenyang Pharmaceutical University	Shenyang Pharmaceutical University, 1, 1% Shenyang Pharmaceutical University 1 publication, 1%
IGI Global	IGI Global, 1, 1% IGI Global 1 publication, 1%
Thomas Telford	Thomas Telford, 1, 1% Thomas Telford 1 publication, 1%
Bentham Science	Bentham Science, 1, 1% Bentham Science 1 publication, 1%
Xi'an Jiaotong University	Xi'an Jiaotong University, 1, 1% Xi'an Jiaotong University 1 publication, 1%
Taylor & Francis	Taylor & Francis, 1, 1% Taylor & Francis 1 publication, 1%
	5 10 15 20 25 30 35

We do not take into account publications that without a DOI.
Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
Statistics recalculated weekly.

{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2020,2021,2022,2023,2024],"ids":[0,0,0,0,0],"codes":[0,0,0,0,0],"imageUrls":["","","","",""],"datasets":[{"label":"Citations number","data":[10,28,24,29,9],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["10","28","24","29","9"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["Journal of Controlled Release","Pharmaceutics","Journal of Nanobiotechnology","Nanoscale","International Journal of Molecular Sciences","Frontiers in Bioengineering and Biotechnology","Molecules","Biomaterials Research","International Journal of Pharmaceutics","Journal of Drug Delivery Science and Technology","International Journal of Biological Macromolecules","Small","ACS applied materials & interfaces","Langmuir","Biotechnology Progress","Nanomedicine","Progress in Materials Science","Biological and Pharmaceutical Bulletin","Transplantation","Hypertension","Frontiers in Cell and Developmental Biology","Cancers","Pharmaceuticals","AAPS PharmSciTech","Applied Biochemistry and Biotechnology","Nano Research","European Journal of Pharmacology","Food Hydrocolloids","Fundamental Research"],"ids":[14351,4502,11794,228,14627,13389,1770,20055,3305,17907,23035,9872,1458,19601,13693,22187,21250,301,19203,14862,12128,22471,1203,12893,331,12211,1631,15729,27258],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/KBGMujzjwr0rGFxg8Kz0qvYdFHkcBo5w0GTtfiiU_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp"],"datasets":[{"label":"","data":[11,5,3,3,2,2,2,2,2,2,2,2,2,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[11,5,3,3,2,2,2,2,2,2,2,2,2,2,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["Elsevier","Multidisciplinary Digital Publishing Institute (MDPI)","Springer Nature","Wiley","Royal Society of Chemistry (RSC)","American Chemical Society (ACS)","Frontiers Media S.A.","Wolters Kluwer Health","Future Medicine","Pharmaceutical Society of Japan","KeAi Communications Co.","Dove Medical Press","Walter de Gruyter","Hindawi Limited","Shenyang Pharmaceutical University","IGI Global","Thomas Telford","Bentham Science","Xi'an Jiaotong University","Taylor & Francis"],"ids":[17,202,8,11,123,40,208,32,6949,159,326,417,4,6921,6085,7845,6981,39,2777,18],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/AN2jnDN59NmKaS4CWLHAGstADL2DbnatQScsFA6C_medium.webp","\/storage\/images\/resized\/KBGMujzjwr0rGFxg8Kz0qvYdFHkcBo5w0GTtfiiU_medium.webp","\/storage\/images\/resized\/jeWDR7NTA9Ab5MVz8Uqjl2RPCndzFjSyl0FaRAHg_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/3SpVxcYL33bOvPq4sHxJLH2NeKNeDloahSUpNiO4_medium.webp","\/storage\/images\/resized\/hqfzhQAjTGlNSRs6yzFNITgjSMm9Jr2QuotJHIvE_medium.webp","","\/storage\/images\/resized\/7FMNeB9SnnAZoNUlPrVuDf3sVkEkt74weJA9emBp_medium.webp","\/storage\/images\/resized\/ljAuhpSMREOSIGmvHXfCUKFQbLqQkW0Ce2oBFgc8_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp"],"datasets":[{"label":"","data":[32,12,12,9,6,5,3,2,2,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[32,12,12,9,6,5,3,2,2,1,1,1,1,1,1,1,1,1,1,1],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}

Metrics

Cite this

GOST |

Cite this

GOST Copy

Oroojalian F. et al. Recent advances in nanotechnology-based drug delivery systems for the kidney. // Journal of Controlled Release. 2020. Vol. 321. pp. 442-462.

GOST all authors (up to 50) Copy

Oroojalian F., Charbgoo F., Hahsemi M., Amani A., Yazdian-Robati R., Mokhtarzadeh A., Ramezani M. H., Hamblin M. Recent advances in nanotechnology-based drug delivery systems for the kidney. // Journal of Controlled Release. 2020. Vol. 321. pp. 442-462.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1016/j.jconrel.2020.02.027

UR - https://doi.org/10.1016%2Fj.jconrel.2020.02.027

TI - Recent advances in nanotechnology-based drug delivery systems for the kidney.

T2 - Journal of Controlled Release

AU - Oroojalian, Fatemeh

AU - Charbgoo, Fahimeh

AU - Hahsemi, Maryam

AU - Amani, Amir

AU - Yazdian-Robati, Rezvan

AU - Mokhtarzadeh, Ahad

AU - Ramezani, Mohammad H.

AU - Hamblin, Michael

PY - 2020

DA - 2020/05/01 00:00:00

PB - Elsevier

SP - 442-462

VL - 321

SN - 0168-3659

SN - 1873-4995

ER -

BibTex

Cite this

BibTex Copy

@article{2020_Oroojalian,

author = {Fatemeh Oroojalian and Fahimeh Charbgoo and Maryam Hahsemi and Amir Amani and Rezvan Yazdian-Robati and Ahad Mokhtarzadeh and Mohammad H. Ramezani and Michael Hamblin},

title = {Recent advances in nanotechnology-based drug delivery systems for the kidney.},

journal = {Journal of Controlled Release},

year = {2020},

volume = {321},

publisher = {Elsevier},

month = {may},

url = {https://doi.org/10.1016%2Fj.jconrel.2020.02.027},

pages = {442--462},

doi = {10.1016/j.jconrel.2020.02.027}

}

Found error?

Publisher

Elsevier

Journal

Journal of Controlled Release

Quartile SCImago

Quartile WOS

Impact factor

10.8

ISSN

01683659 (Print)
18734995 (Electronic)